JP2006508090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006508090A5 JP2006508090A5 JP2004547613A JP2004547613A JP2006508090A5 JP 2006508090 A5 JP2006508090 A5 JP 2006508090A5 JP 2004547613 A JP2004547613 A JP 2004547613A JP 2004547613 A JP2004547613 A JP 2004547613A JP 2006508090 A5 JP2006508090 A5 JP 2006508090A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- hydrogen
- group selected
- aryl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10251170A DE10251170A1 (de) | 2002-10-31 | 2002-10-31 | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| PCT/EP2003/012049 WO2004039784A1 (de) | 2002-10-31 | 2003-10-30 | Neue phenylethanolaminderivate und deren verwendung als beta-3-agonisten |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006508090A JP2006508090A (ja) | 2006-03-09 |
| JP2006508090A5 true JP2006508090A5 (enExample) | 2006-12-14 |
Family
ID=32103286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004547613A Pending JP2006508090A (ja) | 2002-10-31 | 2003-10-30 | 新規β−アゴニスト、それらの製造方法及び医薬組成物としてのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1558583A1 (enExample) |
| JP (1) | JP2006508090A (enExample) |
| AU (1) | AU2003278157A1 (enExample) |
| CA (1) | CA2504213A1 (enExample) |
| DE (1) | DE10251170A1 (enExample) |
| WO (1) | WO2004039784A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2349470T3 (es) * | 2004-02-14 | 2011-01-03 | Boehringer Ingelheim International Gmbh | Nuevos beta-2-agonistas de acción de larga duración y su utilización como medicamentos. |
| US7405232B2 (en) | 2004-02-14 | 2008-07-29 | Boehringer Ingelheim International Gmbh | Long acting beta-2 agonists and their use as medicaments |
| DE102004021779A1 (de) | 2004-04-30 | 2005-11-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| CA2580170A1 (en) * | 2004-10-18 | 2006-04-27 | Boehringer Ingelheim International Gmbh | Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract |
| DE102005052102A1 (de) * | 2005-10-28 | 2007-05-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| DE102005052101A1 (de) * | 2005-10-28 | 2007-05-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| DE102005052103A1 (de) * | 2005-10-28 | 2007-05-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| DE102005052127A1 (de) | 2005-10-28 | 2007-05-03 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| CA2632444A1 (en) * | 2005-12-19 | 2007-06-28 | Boehringer Ingelheim International Gmbh | Use of aminoalcohol derivatives for the treatment of overactive bladder |
| GB0705400D0 (en) | 2007-03-21 | 2007-05-02 | Univ Aberdeen | Therapeutic compounds andm their use |
| WO2008132162A1 (en) * | 2007-04-26 | 2008-11-06 | Boehringer Ingelheim International Gmbh | 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments |
| GB0817208D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
| GB0817207D0 (en) | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | therapeutic apsac compounds and their use |
| GB201311361D0 (en) | 2013-06-26 | 2013-08-14 | Pimco 2664 Ltd | Compounds and their therapeutic use |
| HRP20211877T1 (hr) | 2014-12-17 | 2022-03-04 | Pimco 2664 Limited | Spojevi n-(4-hidroksi-4-metil-cikloheksil)-4-fenil-benzensulfonamida i n-(4-hidroksi-4-metil-cikloheksil)-4- (2-piridil)-benzensulfonamida i njihova terapijska uporaba |
| GB202304652D0 (en) * | 2023-03-29 | 2023-05-10 | Atrogi Ab | New compounds and medical uses thereof |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2943090A (en) * | 1957-09-23 | 1960-06-28 | American Cyanamid Co | Substituted piperazines and method of preparing the same |
| US3092636A (en) * | 1959-10-21 | 1963-06-04 | Upjohn Co | Alpha-[2-(1-alkyleneimino) ethylamino]-alkanophenones and the corresponding alcohols |
| GB1200886A (en) * | 1966-09-23 | 1970-08-05 | Allen & Hanburys Ltd | Phenylaminoethanol derivatives |
| DE2115926C3 (de) * | 1971-04-01 | 1978-05-03 | C.H. Boehringer Sohn, 6507 Ingelheim | 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel |
| DE2833140A1 (de) * | 1978-07-28 | 1980-02-07 | Boehringer Sohn Ingelheim | Neue n-substituierte heterocyclen |
| JPS6183147A (ja) * | 1984-09-28 | 1986-04-26 | Nippon Chemiphar Co Ltd | 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤 |
| JPH08165276A (ja) * | 1994-12-14 | 1996-06-25 | Dainippon Pharmaceut Co Ltd | ２−アルキルアミノ−１−フェニルエタノール誘導体 |
| GB9525177D0 (en) * | 1995-12-08 | 1996-02-07 | Glaxo Group Ltd | Chemical compounds |
| JP3845452B2 (ja) * | 1996-04-05 | 2006-11-15 | ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーシヨン・シヤンテイフイツク・（エス．セー．エール．アー．エス） | α１―交感神経受容体拮抗薬 |
| US6541669B1 (en) * | 1998-06-08 | 2003-04-01 | Theravance, Inc. | β2-adrenergic receptor agonists |
| UA73965C2 (en) * | 1999-12-08 | 2005-10-17 | Theravance Inc | b2 ADRENERGIC RECEPTOR ANTAGONISTS |
-
2002
- 2002-10-31 DE DE10251170A patent/DE10251170A1/de not_active Withdrawn
-
2003
- 2003-10-30 CA CA002504213A patent/CA2504213A1/en not_active Abandoned
- 2003-10-30 AU AU2003278157A patent/AU2003278157A1/en not_active Abandoned
- 2003-10-30 EP EP03769472A patent/EP1558583A1/de not_active Withdrawn
- 2003-10-30 JP JP2004547613A patent/JP2006508090A/ja active Pending
- 2003-10-30 WO PCT/EP2003/012049 patent/WO2004039784A1/de not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006508090A5 (enExample) | ||
| RU2219167C2 (ru) | N-замещенные аминотетралины как лиганды для рецептора y5 нейропептида y, полезные при лечении ожирения и других расстройств | |
| DE69624536T2 (de) | Hydroxamsäurederivate verwendbar zur Hemmung von Gelatinase | |
| KR0183374B1 (ko) | 혈관평활근 이완작용을 가진 화합물과 그의 제조방법 | |
| RU2011103741A (ru) | Композиции и способы лечения заболевания сетчатки | |
| JPS5993054A (ja) | イソキノリンスルホン酸アミド誘導体 | |
| JP2005530811A5 (enExample) | ||
| RU2001114978A (ru) | N-ариламиды антраниловой кислоты и тиоантраниловой кислоты | |
| NO20056007L (no) | Dobbel NK1/NK3 antagonister for behandling av schizofreni | |
| RU2003134544A (ru) | Амиды антраниловой кислоты, способы их получения, их применение в качестве антиаритмических средств, а также содержащие их фармацевтические композиции | |
| RU2003119153A (ru) | Орто-, мета-замещенные бис-арильные соединения, способ их получения, их применение в качестве медикаментов, а также содержащие их фармацевтические композиции | |
| DE3207033C2 (de) | Amidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel | |
| JPS60209559A (ja) | 置換スルホンアミドベンズアミド及びその製法 | |
| CH616674A5 (enExample) | ||
| DE60220255T2 (de) | N-phenylarylsulfonamidverbindung, arzneimittel, das diese verbindung als wirkstoff enthält, zwischenprodukt für die verbindung und verfahren zu dessen herstellung | |
| ATE268752T1 (de) | Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung | |
| RU2007128085A (ru) | Соли четвертичного аммония в качестве антагонистов м3 | |
| JP2005517677A5 (enExample) | ||
| JPS61148151A (ja) | アミノ‐プロパノール‐誘導体、その製法及びこれを含有する心臓‐及び循環疾病の治療並びに予防のための薬剤 | |
| JP2005511602A5 (enExample) | ||
| JP2006510606A5 (enExample) | ||
| JP2006512321A5 (enExample) | ||
| JP2001515509A (ja) | 新規キノリン−およびナフタレンカルボキサミド、医薬組成物およびカルパインの阻害方法 | |
| RU2004117548A (ru) | Амиды антраниловой кислоты и их применение в фармацевтике | |
| RU2009113616A (ru) | Тартратные производные для применения в качестве ингибиторов фактора свертывания крови ixa |